These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2152338

  • 41. [Bronchological methods of treating chronic suppurative lung diseases].
    Pribylova NN.
    Sov Med; 1980; (12):78-80. PubMed ID: 7221724
    [No Abstract] [Full Text] [Related]

  • 42. Study of broncho-pulmonary suppurative diseases with special reference to bacteriology.
    Jain SM, Sepaha GC, Mehta J.
    Indian J Chest Dis; 1974 Oct; 16(4):400-5. PubMed ID: 4469267
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. A multicenter open clinical trial of cefotetan in the treatment of peritonitis.
    Mason B, Bax R.
    Chemioterapia; 1987 Jun; 6(2 Suppl):479-80. PubMed ID: 3334606
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [The role of anaerobic non-sporulating bacteria in urinary tract infections].
    Hudác A, Záhradníková I, Lamosová M, Popluhárová M, Filo I.
    Cesk Epidemiol Mikrobiol Imunol; 1991 Mar; 40(2):85-8. PubMed ID: 1827365
    [Abstract] [Full Text] [Related]

  • 50. [Bacteriologic and clinical observations on the gentamicin effect in pneumology].
    Mariani B, Velluti G.
    G Ital Chemioter; 1969 Mar; 16(1):178-86. PubMed ID: 5404095
    [No Abstract] [Full Text] [Related]

  • 51. Anaerobic microbiology: time to rejuvenate.
    Bharadwaj R.
    Indian J Med Microbiol; 2012 Mar; 30(1):3-5. PubMed ID: 22361753
    [No Abstract] [Full Text] [Related]

  • 52. Bacteriological and clinical evaluation of cefotetan in the treatment of severe infections in hospitalized patients.
    Romanelli G, Agabiti-Rosei E, Giustina A, Guarnera L, Muiesan ML, Pelizzari G, Turano A.
    Drugs Exp Clin Res; 1988 Mar; 14(6):411-7. PubMed ID: 3215108
    [Abstract] [Full Text] [Related]

  • 53. Chapter 2-1. Anaerobic infections (individual fields): respiratory infections.
    Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections, Japanese Association for Anaerobic Infection Research.
    J Infect Chemother; 2011 Jul; 17 Suppl 1():42-6. PubMed ID: 21728090
    [No Abstract] [Full Text] [Related]

  • 54. [Diagnosis of anaerobic infections].
    Bernhardt H, Knoke M.
    Z Arztl Fortbild (Jena); 1986 Jul; 80(8):323-5. PubMed ID: 3524036
    [No Abstract] [Full Text] [Related]

  • 55. Clinical study on the efficacy of clofoctol in the treatment of infectious respiratory diseases.
    Danesi R, Del Tacca M.
    Int J Clin Pharmacol Res; 1985 Jul; 5(3):175-9. PubMed ID: 4018951
    [Abstract] [Full Text] [Related]

  • 56. Asian multicenter trial of cefoperazone in respiratory tract infection.
    Matsumoto K, Chung HY, Hsieh WC.
    Clin Ther; 1984 Jul; 6(6):824-38. PubMed ID: 6391668
    [Abstract] [Full Text] [Related]

  • 57. [Infection causing pathogens in the area of the upper respiratory tract. Bacteriologic diagnosis and chemotherapy from the viewpoint of the bacteriologist].
    Burkhardt F.
    HNO; 1984 Nov; 32(11):441-9. PubMed ID: 6392219
    [Abstract] [Full Text] [Related]

  • 58. Cefotaxime in the treatment of lower respiratory tract infections.
    Beumer HM, Veldkamp J, Deleers L.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):605-10. PubMed ID: 6321367
    [Abstract] [Full Text] [Related]

  • 59. [Treatment of acute and bacterial lower respiratory tract infections with roxithromycin].
    Chabbou A, Belalgia S, Kamel A, Megdiche L.
    Tunis Med; 1992 Oct; 70(10):467-71. PubMed ID: 1295159
    [No Abstract] [Full Text] [Related]

  • 60. Cefotetan: a second-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.
    Gribble MJ.
    CMAJ; 1994 Sep 01; 151(5):537-42. PubMed ID: 8069799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.